Previous Issue
Volume 5, September
 
 

Obesities, Volume 5, Issue 4 (December 2025) – 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
11 pages, 305 KB  
Article
Appetite Assessment Using the Arabic CNAQ Following a Telenutrition Weight-Loss Intervention with Health Coaching and Telemonitoring: A Cross-Sectional Analysis
by Sarah N. Alsharif, Noura M. S. Eid, Noor A. Hakim, Najlaa M. M. Jawad and Soaad F. Alsulami
Obesities 2025, 5(4), 73; https://doi.org/10.3390/obesities5040073 - 9 Oct 2025
Abstract
Obesity is closely associated with appetite dysregulation, influenced by behavioral, hormonal, and neurological factors. The Council on Nutrition Appetite Questionnaire (CNAQ) is a validated tool, translated into Arabic, but its application in weight-loss interventions remains underexplored. This secondary cross-sectional analysis evaluated whether the [...] Read more.
Obesity is closely associated with appetite dysregulation, influenced by behavioral, hormonal, and neurological factors. The Council on Nutrition Appetite Questionnaire (CNAQ) is a validated tool, translated into Arabic, but its application in weight-loss interventions remains underexplored. This secondary cross-sectional analysis evaluated whether the Arabic CNAQ can differentiate appetite levels after a 6-month telenutrition weight-loss intervention supported by telemonitoring and health coaching, and whether appetite is associated with weight-loss outcomes. A total of 36 participants were assessed: the intervention group (n = 21), who completed the program, and the control group (n = 15), who received no continuous support. Appetite was measured using the CNAQ after 6 months. Independent-samples t-tests and Mann–Whitney U tests were applied to compare appetite scores, while Chi-square tests were used for appetite categories. Results showed mean CNAQ scores of 27.87 (SD = 2.64) for the control group and 26.86 (SD = 4.46) for the intervention group (p = 0.402). Most participants reported moderate appetite (93.3% control; 76.2% intervention), with no significant between-group differences (p = 0.367). Although differences were not statistically significant, the findings demonstrate the feasibility of using the Arabic CNAQ in telehealth weight management. Larger studies with repeated measures are needed to confirm its utility in clinical and dietetic practice. Full article
Show Figures

Figure 1

14 pages, 321 KB  
Systematic Review
Impacts of Glucagon-like Peptide-1 Receptor-Agonist (GLP-1 RA) Treatment for Metabolic Disturbances and Weight Gain in Patients on Clozapine/Olanzapine: A Systematic Review
by Karan Varshney, Shivani Panda, Hilary Fernando, Sergiu Sava and Taimur Khan
Obesities 2025, 5(4), 72; https://doi.org/10.3390/obesities5040072 - 9 Oct 2025
Abstract
Clozapine and olanzapine are important medications in the management of psychiatric conditions such as schizophrenia. However, metabolic disturbances and weight gain are common side effects of these drugs. We aimed to evaluate the effects of GLP-1 RAs treatment for metabolic disturbances and weight [...] Read more.
Clozapine and olanzapine are important medications in the management of psychiatric conditions such as schizophrenia. However, metabolic disturbances and weight gain are common side effects of these drugs. We aimed to evaluate the effects of GLP-1 RAs treatment for metabolic disturbances and weight gain in patients on clozapine/olanzapine. For this systematic review, searches were conducted in eight different databases. After screening, outcome data was synthesized regarding weight gain and biochemical and clinical indicators of metabolic disturbance, as well as for adverse events/side effects, and any other benefits of GLP-1 RA treatment. A total of 14 studies were included in this medical systematic review, of which four were unique randomized control trials (RCTs), with study contexts including Australia and Denmark. GLP-1 RAs that were utilized include semaglutide, exenatide, and liraglutide. It was consistently demonstrated across studies that, when followed-up, those on GLP-1 RAs had achieved statistically lower levels of weight gain compared to those receiving placebo. A similar effect was seen on fasting glucose levels and glycated haemoglobin levels. Effects on other metabolic parameters were inconsistent. There were minimal gastrointestinal, psychological, cardiac, and other side effects noted across studies. GLP-1 RAs may offer utility in addressing the metabolic side effects of olanzapine/clozapine, but further research is needed. There remains a need to better understand impacts and potential side effects in larger and more diverse populations, as well as a need to better evaluate the long-term outcomes for patients. Full article
Show Figures

Figure 1

15 pages, 472 KB  
Article
Body Mapping as Risk Factors for Non-Communicable Diseases in Ghana: Evidence from Ghana’s 2023 Nationwide Steps Survey
by Pascal Kingsley Mwin, Benjamin Demah Nuertey, Joana Ansong, Edmond Banafo Nartey, Leveana Gyimah, Philip Teg-Nefaah Tabong, Emmanuel Parbie Abbeyquaye, Priscilla Foriwaa Eshun, Yaw Ampem Amoako, Terence Totah, Frank John Lule, Sybil Sory Opoku Asiedu and Abraham Hodgson
Obesities 2025, 5(4), 71; https://doi.org/10.3390/obesities5040071 - 3 Oct 2025
Viewed by 193
Abstract
Non-communicable diseases (NCDs) are the leading global cause of death, causing over 43 million deaths in 2021, including 18 million premature deaths, disproportionately affecting low- and middle-income countries. NCDs also incur significant economic losses, estimated at USD 7 trillion from 2011 to 2025, [...] Read more.
Non-communicable diseases (NCDs) are the leading global cause of death, causing over 43 million deaths in 2021, including 18 million premature deaths, disproportionately affecting low- and middle-income countries. NCDs also incur significant economic losses, estimated at USD 7 trillion from 2011 to 2025, despite low prevention costs. This study evaluated body mapping indicators: body mass index (BMI), waist circumference, and waist-to-hip ratio—for predicting NCD risk, including hypertension, diabetes, and cardiovascular diseases, using data from a nationally representative survey in Ghana. The study sampled 5775 participants via multistage stratified sampling, ensuring proportional representation by region, urban/rural residency, age, and gender. Ethical approval and informed consent were obtained. Anthropometric and biochemical data, including height, weight, waist and hip circumferences, blood pressure, fasting glucose, and lipid profiles, were collected using standardized protocols. Data analysis was conducted with STATA 17.0, accounting for complex survey design. Significant sex-based differences were observed: men were taller and lighter, while women had higher BMI and waist/hip circumferences. NCD prevalence increased with age, peaking at 60–69 years, and was higher in females. Lower education and marital status (widowed, divorced, separated) correlated with higher NCD prevalence. Obesity and high waist circumference strongly predicted NCD risk, but individual anthropometric measures lacked screening accuracy. Integrated screening and tailored interventions are recommended for improved NCD detection and management in resource-limited settings. Full article
Show Figures

Figure 1

13 pages, 478 KB  
Article
The Magnitude of Dyslipidemia and Factors Associated with Elevated LDL-C Among Black South Africans with Type 2 Diabetes Mellitus at a Tertiary Hospital
by Mashudu Nemukula, Siphesihle Mkhwanazi, Tumelo Jessica Mapheto, Arun Kumar Malaisamy, Neel Sarovar Bhavesh, Olebogeng Harold Majane and Sechene Stanley Gololo
Obesities 2025, 5(4), 70; https://doi.org/10.3390/obesities5040070 - 27 Sep 2025
Viewed by 242
Abstract
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health challenge with a significant impact on human life. The current study aims to provide a comprehensive analysis of the magnitude of dyslipidemia and the factors associated with elevated LDL-C levels among [...] Read more.
Background/Objectives: Type 2 diabetes mellitus (T2DM) is a major global public health challenge with a significant impact on human life. The current study aims to provide a comprehensive analysis of the magnitude of dyslipidemia and the factors associated with elevated LDL-C levels among Black South Africans with T2DM. Methods: This was a cross-sectional study conducted in a tertiary hospital. Blood samples for glycated hemoglobin (HbA1c) and lipid profile were collected from the study participants and analyzed using Siemens Atellica™ analyzer. The data was entered into Microsoft excel and analyzed using SPSS version 24. Bivariate and multivariate logistic regression was employed to identify variables significantly associated with the outcomes, with a p-value  ≤  0.05 and a 95% confidence interval. Results: A total of 194 study participants with T2DM were recruited in the study. The overall prevalence of dyslipidemia was 90.72%. Of those with dyslipidemia, 40.9% had an isolated dyslipidemia, 39.7% had a combined dyslipidemia and 19.3% had atherogenic dyslipidemia. Significant factors associated with elevated levels of LDL-C included age, non-adherence to treatment (NAT) and duration. However, after multivariate analysis, NAT was found to be an independent associated factor with elevated levels of LDL-C (AOR: 4.596; 95% CI: 0.177–2.874; p = 0.027). Conclusions: Our study found that dyslipidemia is highly prevalent among Black South African patients with T2DM at a tertiary hospital, despite the use of lipid-lowering therapy. NAT was significantly associated with elevated levels of LDL-C. However, it is important to note that the study employed a cross-sectional design, conducted at a single hospital, which may impair the generalizability of the findings. Full article
Show Figures

Figure 1

19 pages, 685 KB  
Article
The Relationship of Education Level, Lifestyle, and Personality to BMI and Obesity Differs Between Men and Women
by Keisuke Kokubun, Kiyotaka Nemoto and Yoshinori Yamakawa
Obesities 2025, 5(4), 69; https://doi.org/10.3390/obesities5040069 - 26 Sep 2025
Viewed by 389
Abstract
Obesity has become a major global health concern, but few studies have examined the determinants of body mass index (BMI, kg/m2) and overweight/obesity (BMI ≥ 25) specifically in women. This study investigated the roles of education, lifestyle, and personality using data [...] Read more.
Obesity has become a major global health concern, but few studies have examined the determinants of body mass index (BMI, kg/m2) and overweight/obesity (BMI ≥ 25) specifically in women. This study investigated the roles of education, lifestyle, and personality using data from a questionnaire survey of 4276 Japanese adults (2215 women and 2061 men) aged 30–79 years. Multiple regression and logistic regression analyses were conducted to identify factors associated with BMI (continuous) and obesity (BMI ≥ 25) in women. The multiple regression results indicated that educational attainment, rest, diet, and conscientiousness were negatively associated with BMI, whereas extraversion and openness were positively associated with BMI. Logistic regression further showed that higher education, regular exercise, sufficient rest, and conscientiousness were associated with non-obesity (BMI < 25), while openness was associated with obesity (BMI ≥ 25). To our knowledge, this is the first study to identify determinants of BMI and obesity in women with a simultaneous focus on education, lifestyle, and personality traits. Full article
Show Figures

Figure 1

20 pages, 610 KB  
Systematic Review
The Combined Effect of the Mediterranean Diet and Physical Activity on the Components of Metabolic Syndrome in Adults: A Systematic Review of Randomised Controlled Trials
by Luiza Teixeira, Diogo Monteiro, Rui Matos, Raúl Antunes and Miguel Jacinto
Obesities 2025, 5(4), 68; https://doi.org/10.3390/obesities5040068 - 25 Sep 2025
Viewed by 636
Abstract
Metabolic syndrome (MetS) is a global public health challenge, characterized by the coexistence of cardiometabolic risk factors such as abdominal obesity, dyslipidaemia, hypertension, and insulin resistance. Non-pharmacological strategies, including the Mediterranean diet (MD) and physical activity (PA), have been widely studied for their [...] Read more.
Metabolic syndrome (MetS) is a global public health challenge, characterized by the coexistence of cardiometabolic risk factors such as abdominal obesity, dyslipidaemia, hypertension, and insulin resistance. Non-pharmacological strategies, including the Mediterranean diet (MD) and physical activity (PA), have been widely studied for their potential to prevent and manage MetS. This systematic review aimed to synthesize the evidence on the combined effect of MD and PA on MetS components in adults, based on randomized controlled trials (RCTs). Twenty-two RCTs published between 2018 and 2024 were included, involving 11,478 participants. The interventions ranged from 8 weeks to 3 years and combined adapted or hypocaloric MDs with moderate-to-high-intensity PA, typically including walking, aerobic exercise, or high-intensity interval training (HIIT), performed 3 to 7 times per week. The combined interventions resulted in reductions in body weight (−2.5 to −7.2 kg), body mass index (−0.7 to −2.2 kg/m2), waist circumference (−5.1 to −7.8 cm), and blood pressure (up to −9.0 mmHg systolic and −6.7 mmHg diastolic). Improvements in HDL cholesterol, triglyceride levels, and insulin sensitivity were also observed. These findings suggest that integrated interventions based on the Mediterranean lifestyle are effective in reducing MetS components and may support future public health strategies. Full article
Show Figures

Figure 1

16 pages, 1228 KB  
Article
Supplementation Effects of Hibiscus sabdariffa L. Flower Aqueous Extract on Body Composition and Metabolism in Eutrophic and Obese Rats
by João Fernando Bernardo da Costa, Alana Louzada Millions Monteiro, Bruna Almeida Nascimento, Clarice Maia Vinagre de Oliveira, Karen Pereira Coutinho, Anderson Junger Teodoro, Barbara Elisabeth Teixeira-Costa and Mariana Sarto Figueiredo
Obesities 2025, 5(4), 67; https://doi.org/10.3390/obesities5040067 - 25 Sep 2025
Viewed by 337
Abstract
Obesity is a chronic, multifactorial disease characterized by excess body fat and is a major risk factor for various metabolic disorders. Bioactive compounds from the diet have been recognized for their role in preventing chronic non-communicable diseases and as adjuvants in managing endocrine–metabolic [...] Read more.
Obesity is a chronic, multifactorial disease characterized by excess body fat and is a major risk factor for various metabolic disorders. Bioactive compounds from the diet have been recognized for their role in preventing chronic non-communicable diseases and as adjuvants in managing endocrine–metabolic dysfunctions. Hibiscus sabdariffa L. (HSL) is rich in bioactive compounds with antioxidant, antihypertensive, and antihyperlipidemic properties. This study evaluated the effects of HSL flower extract supplementation on body composition, lipid profile, and biochemical parameters in both eutrophic and high-fat diet-induced obese rats. Thirty-two Wistar rats were assigned to four groups: control, control plus HSL extract, high-fat diet, and high-fat diet plus HSL extract. The extract was administered orally at 150 mg kg−1 for thirty days. Dual-energy X-ray absorptiometry revealed that HSL supplementation significantly attenuated fat mass gain (from 98 g to 75 g) and adiposity indices (10.23 to 8.86) in obese rats without altering total body mass. Moreover, the HSL extract improved lipid profiles by reducing LDL cholesterol from 23 to 13 mg dL−1 and exhibited potential hepatoprotective effects linked with decreased ALT (40 to 26.7 U L−1) and total bilirubin (0.12 to 0.07 mg dL−1) levels. Although glucose metabolism parameters had no significant differences, a trend toward improved insulin sensitivity was observed. These results suggest that the aqueous HSL extract may exert cardioprotective, hepatoprotective, and anti-obesity effects, supporting its potential as a complementary therapeutic agent in obesity and related metabolic disorders. Full article
(This article belongs to the Special Issue The Impact of Food Compounds on Obesity Mechanisms)
Show Figures

Figure 1

Previous Issue
Back to TopTop